Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Apr 22, 2016 $18.16 $18.16 $18.16 $18.16 112 125
Apr 21, 2016 $17.01 $17.01 $17.01 $17.01 98 941
Apr 20, 2016 $16.41 $16.41 $16.41 $16.41 45 527
Apr 19, 2016 $16.57 $16.57 $16.57 $16.57 94 554
Apr 18, 2016 $17.06 $17.06 $17.06 $17.06 69 869
Apr 15, 2016 $17.07 $17.07 $17.07 $17.07 62 598
Apr 14, 2016 $16.72 $16.72 $16.72 $16.72 87 342
Apr 13, 2016 $17.17 $17.17 $17.17 $17.17 200 924
Apr 12, 2016 $16.15 $16.15 $16.15 $16.15 86 237
Apr 11, 2016 $15.66 $15.66 $15.66 $15.66 72 635
Apr 08, 2016 $15.85 $15.85 $15.85 $15.85 132 840
Apr 07, 2016 $15.87 $15.87 $15.87 $15.87 208 184
Apr 06, 2016 $16.88 $16.88 $16.88 $16.88 141 661
Apr 05, 2016 $15.75 $15.75 $15.75 $15.75 143 922
Apr 04, 2016 $16.24 $16.24 $16.24 $16.24 187 511
Apr 01, 2016 $14.55 $14.55 $14.55 $14.55 238 051
Mar 31, 2016 $13.98 $13.98 $13.98 $13.98 418 942
Mar 30, 2016 $13.83 $13.83 $13.83 $13.83 187 532
Mar 29, 2016 $13.96 $13.96 $13.96 $13.96 176 400
Mar 28, 2016 $13.55 $13.55 $13.55 $13.55 117 900
Mar 24, 2016 $13.70 $13.70 $13.70 $13.70 72 300
Mar 23, 2016 $13.82 $13.82 $13.82 $13.82 83 700
Mar 22, 2016 $14.31 $14.31 $14.31 $14.31 116 300
Mar 21, 2016 $14.37 $14.37 $14.37 $14.37 179 900
Mar 18, 2016 $13.75 $13.75 $13.75 $13.75 222 300
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT